The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China
Open accessAbstract
Background Crucial roles of hematologic and immunologic responses in progression of coronavirus disease 2019 (COVID-19) remain largely unclear. Objective We sought to address the dynamic changes in hematologic and immunologic biomarkers and their associations with severity and outcomes of COVID-19. Methods A retrospective study including 548 patients with COVID-19 with clarified outcome (discharged or deceased) from a national cohort in China was performed. Cross-sectional and longitudinal variations were compared and the associations with different severity and outcomes were analyzed. Results On admission, the counts of lymphocytes, T-cell subsets, eosinophils, and platelets decreased markedly, especially in severe/critical and fatal patients. Increased neutrophil count and neutrophils-to-lymphocytes ratio were predominant in severe/critical cases or nonsurvivors. During hospitalization, eosinophils, lymphocytes, and platelets showed an increasing trend in survivors, but maintained lower levels or dropped significantly afterwards in nonsurvivors. Nonsurvivors kept a high level or showed an upward trend for neutrophils, IL-6, procalcitonin, D-dimer, amyloid A protein, and C-reactive protein, which were kept stable or showed a downward trend in survivors. Positive correlation between CD8+ T-cell and lymphocytes count was found in survivors but not in nonsurvivors. A multivariate Cox regression model suggested that restored levels of lymphocytes, eosinophils, and platelets could serve as predictors for recovery, whereas progressive increases in neutrophils, basophils, and IL-6 were associated with fatal outcome. Conclusions Hematologic and immunologic impairment showed a significantly different profile between survivors and nonsurvivors in patients with COVID-19 with different severity. The longitudinal variations in these biomarkers could serve to predict recovery or fatal outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0498-4 · Cited by 175
RetractedWang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0424-9 · Cited by 161
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationClinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · cited 1×
“onset to admission 13 (9-18) 13 (10-18)* 9 (6-17) 13 (9-16) 13 (9-16) 14 (7-18) 15 (8-21) 17 (11-24)* 9 (6-18) 9 (6-23) 23 (12-54)* 7 (3-9)”
Self-citationA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationWu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Self-citationDysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Self-citationClinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Effective treatment of severe COVID-19 patients with tocilizumab
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,647
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1643-8 · Cited by 2,031
Self-citationFunctional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768 · cited 2×
“onset to admission 13 (9-18) 13 (10-18)* 9 (6-17) 13 (9-16) 13 (9-16) 14 (7-18) 15 (8-21) 17 (11-24)* 9 (6-18) 9 (6-23) 23 (12-54)* 7 (3-9)”
Lippi, G., Plebani, M., & Henry, B. M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.022 · Cited by 1,706
Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102763 · Cited by 1,702
Self-citationChannappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,419
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020) · National Science Review · doi:10.1093/nsr/nwaa041 · Cited by 1,295
Pedersen, S. F., & Ho, Y.-C. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137647 · Cited by 1,137 · cited 2×
“onset to admission 13 (9-18) 13 (10-18)* 9 (6-17) 13 (9-16) 13 (9-16) 14 (7-18) 15 (8-21) 17 (11-24)* 9 (6-18) 9 (6-23) 23 (12-54)* 7 (3-9)”
Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C., Zhang, M., Tan, J., Xu, Y., Song, R., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02374-0 · Cited by 1,082
Self-citationHyperferritinemia and inflammation
Kernan, K. F., & Carcillo, J. A. (2017) · International Immunology · doi:10.1093/intimm/dxx031 · Cited by 638
Wong, R. S. M., Wu, A., To, K. F., Lee, N., Lam, C. W. K., Wong, C. K., Chan, P. K. S., Ng, M. H. L., Yu, L. M., Hui, D. S., et al. (2003) · BMJ · doi:10.1136/bmj.326.7403.1358 · Cited by 561
T cell-mediated immune response to respiratory coronaviruses
Channappanavar, R., Zhao, J., & Perlman, S. (2014) · Immunologic Research · doi:10.1007/s12026-014-8534-z · Cited by 512
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Zhao, J., Zhao, J., Mangalam, A. K., Channappanavar, R., Fett, C., Meyerholz, D. K., Agnihothram, S., Baric, R. S., David, C. S., & Perlman, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.006 · Cited by 496
Chu, H., Zhou, J., Wong, B. H.-Y., Li, C., Chan, J. F.-W., Cheng, Z.-S., Yang, D., Wang, D., Lee, A. C.-Y., Li, C., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv380 · Cited by 448 · cited 2×
“onset to admission 13 (9-18) 13 (10-18)* 9 (6-17) 13 (9-16) 13 (9-16) 14 (7-18) 15 (8-21) 17 (11-24)* 9 (6-18) 9 (6-23) 23 (12-54)* 7 (3-9)”
Human immunopathogenesis of severe acute respiratory syndrome (SARS)
Cameron, M. J., Bermejo-Martin, J. F., Danesh, A., Muller, M. P., & Kelvin, D. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.02.014 · Cited by 391
Ng, D. L., Al Hosani, F., Keating, M. K., Gerber, S. I., Jones, T. L., Metcalfe, M. G., Tong, S., Tao, Y., Alami, N. N., Haynes, L. M., et al. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.10.024 · Cited by 384
He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 366
Self-citationLiu, F., Xu, A., Zhang, Y., Xuan, W., Yan, T., Pan, K., Yu, W., & Zhang, J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.013 · Cited by 346
Characterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome
Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S., Liu, J., Luo, W., Chen, T., Qin, Q., & Deng, P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-857oc · Cited by 323
Self-citationHe, Z., Zhao, C., Dong, Q., Zhuang, H., Song, S., Peng, G., & Dwyer, D. E. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.07.014 · Cited by 258
Buck, M., Gouwy, M., Wang, J., Snick, J., Opdenakker, G., Struyf, S., & Damme, J. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160418114600 · Cited by 248
Self-citationInteractions between neutrophils and cytokines in blood and alveolar spaces during ARDS.
Chollet-Martin, S., Jourdain, B., Gibert, C., Elbim, C., Chastre, J., & Gougerot-Pocidalo, M. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810592 · Cited by 240
Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients
Wang, J.-T., Sheng, W.-H., Fang, C.-T., Chen, Y.-C., Wang, J.-L., Yu, C.-J., Chang, S.-C., & Yang, P.-C. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1005.030640 · Cited by 223
Self-citationThrombocytopenia in patients with severe acute respiratory syndrome (review)
Yang, M., Ng, M. H., & Li, C. K. (2005) · Hematology · doi:10.1080/10245330400026170 · Cited by 185
Cowardin, C. A., Buonomo, E. L., Saleh, M. M., Wilson, M. G., Burgess, S. L., Kuehne, S. A., Schwan, C., Eichhoff, A. M., Koch-Nolte, F., Lyras, D., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.108 · Cited by 185
Pinto, R. A., Arredondo, S. M., Bono, M. R., Gaggero, A. A., & Díaz, P. V. (2006) · Pediatrics · doi:10.1542/peds.2005-2119 · Cited by 180
Expression of Lymphocytes and Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome
Cui, W., Fan, Y., Wu, W., Zhang, F., Wang, J., & Ni, A. (2003) · Clinical Infectious Diseases · doi:10.1086/378587 · Cited by 180
Self-citationArabi, Y. M., Al-Omari, A., Mandourah, Y., Al-Hameed, F., Sindi, A. A., Alraddadi, B., Shalhoub, S., Almotairi, A., Al Khatib, K., Abdulmomen, A., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002621 · Cited by 180
Yip, T. T. C. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.031229 · Cited by 105
Ju, X., Xu, H.-J., Yong, Y., An, L., Jiao, P., & Liao, M. (2014) · animal · doi:10.1017/s1751731114001268 · Cited by 100
Niu, P., Zhang, S., Zhou, P.-P., Huang, B., Deng, Y. L., Qin, K., Wang, P., Wang, W., Wang, X., Zhou, J., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy311 · Cited by 73
Li, T., Qiu, Z., Han, Y. C., et al. (2003) · PubMed · Cited by 43
Lee, Y.-S., Chen, C., Chao, A., Chen, E.-S., Wei, M., Chen, L.-K., Yang, K. D., Lin, M.-C., Wang, Y.-H., Liu, J.-W., et al. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-132 · Cited by 39
Self-citationClinical and Laboratory Findings of Middle East Respiratory Syndrome Coronavirus Infection
Hwang, S.-M., Na, B.-J., Jung, Y., Lim, H.-S., Seo, J.-E., Park, S.-A., Cho, Y.-S., Song, E.-H., Seo, J.-Y., Kim, S., et al. (2018) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2018.187 · Cited by 37
A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan
Wang, Y.-H., Lin, A.-S., Chao, T.-Y., Lu, S., Liu, J.-W., Chen, S.-S., & Lin, M. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2311-8 · Cited by 31
Self-citationMetformin, neutrophils and COVID-19 infection
Dalan, R. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108230 · Cited by 31
Reis, F. G., Marques, R. H., Starling, C. M., Almeida-Reis, R., Vieira, R. P., Cabido, C., da Silva, L. F. F., Lanças, T., Dolhnikoff, M., Martins, M. A., et al. (2012) · Experimental Lung Research · doi:10.3109/01902148.2012.704484 · Cited by 18
Flick, H., Arns, B. M., Bolitschek, J., Bucher, B., Cima, K., Gingrich, E., Handzhiev, S., Hochmair, M. J., Horak, F., Idzko, M., et al. (2020) · Wiener klinisches Magazin · doi:10.1007/s00740-020-00350-4 · Cited by 9
Cited by
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
Self-citationAging in COVID-19: Vulnerability, immunity and intervention
Chen, Y., Klein, S. L., Garibaldi, B. T., Li, H., Wu, C., Osevala, N. M., Li, T., Margolick, J. B., Pawelec, G., & Leng, S. X. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101205 · Cited by 1,007
A dynamic COVID-19 immune signature includes associations with poor prognosis
Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946
Predictors of COVID‐19 severity: A literature review
Gallo Marin, B., Aghagoli, G., Lavine, K., Yang, L., Siff, E. J., Chiang, S. S., Salazar‐Mather, T. P., Dumenco, L., Savaria, M. C., Aung, S. N., et al. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2146 · Cited by 819
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 520
Metadata
- Authors
- Chen, R., Sang, L., Jiang, M., Yang, Z., Jia, N., Fu, W., Xie, J., Guan, W., Liang, W., Ni, Z., Hu, Y., Liu, L., Shan, H., Lei, C., Peng, Y., Wei, L., Liu, Y., Hu, Y., Peng, P., Wang, J., Liu, J., Chen, Z., Li, G., Zheng, Z., Qiu, S., Luo, J., Ye, C., Zhu, S., Zheng, J., Zhang, N., Li, Y., He, J., Li, J., Li, S., & Zhong, N.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 146
- Issue
- 1
- Pages
- 89-100
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W3023125802
- Cited by
- 380
- References
- 52
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.